Key figures
Key figures
Overview
Our long-term client required a strategic partner to fit out existing fallow areas and increase production capacity for dry media manufacturing. The project demanded validated ISO 8 cleanroom environments to scale up the production of cell culture media for vaccines and biologics. Key requirements included integrating process and utility systems within a live manufacturing site and strict adherence to cGMP/MHRA and ISO 13485:2016 regulatory standards.
Technical mastery
By leveraging the strategic site intelligence gained during the ‘Define’ phases (Phases 1 & 1.5), our in-house team provided the foundational knowledge required for a seamless transition into execution. Our "Inside-Out" design philosophy ensured that process requirements dictated the facility operability, resulting in an optimised, high-specification environment. We delivered:
-
Split-level engineering: Engineered a unique split-level solution for powder handling, processing and transferring systems over three levels in line with cGMP.
-
3D modelling: Leveraged advanced 3D modelling to de-risk construction within the constrained site, simulating installation paths to guarantee flawless execution.
-
Integrated compliance: Implemented novel technologies fully compliant with DSEAR/ATEX, COSHH LEV, and SIL II standards, ensuring every safety feature was baked into the "inside-out" design.
-
Operational continuity strategy: Managed a pragmatic construction schedule that segregated the manufacturing area from construction sites, allowing for limited, programmed shutdowns. during critical stages to maintain existing production cycles.
Benefits
By selecting Equans Sci-Tech as a single point of contact, the client secured integrated certainty. Our ability to manage the entire value chain reduced procurement complexity and provided a cast-iron guarantee of streamlined delivery.
Key results:
-
Speed to value: The facility achieved an immediate capacity increase with the installation of the second manufacturing line, providing 100% additional manufacturing capability in 2021, enabling the client to meet the rising global demand for vaccines and biologics therapies without delay.
-
Lifecycle excellence: The repurposed fallow space now functions as a state-of-the-art processing facility with 19 integrated processes, designed for long-term durability and maximum ROI.
-
Operational resilience: Our strategic segregation approach maintained the client’s existing revenue streams throughout the build, ensuring zero unplanned downtime and protecting employee well-being.
-
Validated Performance: The delivery of a fully compliant ISO 8 environment ensures the client remains at the forefront of high-value media manufacturing with a future-ready, scalable asset.
Explore our full range of capabilities.
At Equans Sci-Tech, we specialise in mission-critical environments where precision is non-negotiable. Whether you are launching a greenfield development or repurposing existing building services, our fully integrated team provides a single point of contact to Define, Design, and Deliver your most complex requirements.
* Formerly known as Bouygues Energies & Services